P&PMED
Geyuan Zhishan is the first biomedical company to focus on the research and application of personalized cancer vaccines. Focus on a standardized system for the prediction and evaluation of new antigens to establish and personalize clinical treatment studies for tumor vaccines. Geyuan’s technology is derived from the State Key Laboratory of Medical Immunology and Medical Immunology of the Second Military Medical University. The company adheres to the "new antigen" + "personalized tumor vaccine"... as a double wing, which can quickly develop targeted personalized cancer prevention and treatment vaccines based on the results of tumor gene mutations, and provide accurate medical solutions for the whole tumor cycle. The company has introduced research and development teams of interdisciplinary scientists such as computational biology, genetic testing, and cellular immunity. It has applied for a number of patents on the frontier precision medical technology such as early tumor screening and personalized tumor vaccines.
P&PMED
Industry:
Biotechnology
Founded:
2018-05-01
Address:
Xuhui, Shanghai, China
Country:
China
Website Url:
http://www.pnp-med.com
Total Employee:
11+
Status:
Active
Total Funding:
1.45 M USD
Technology used in webpage:
Nginx HiChina DNS Baidu Cloud
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Current Employees Featured
Founder
Investors List
Empower Investment
Empower Investment investment in Angel Round - P&PMed
